Showing results (131-140 of 234) with videos related to

Sort By:
Pageof 24
Journal of the American College of Cardiology|November 11, 2003
From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomesEric D Peterson, Padma Kaul, Ronald G Kaczmarek, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2018
Ambulance use, distance and outcomes in patients with suspected cardiovascular disease: a registry-based geographic information system studyNariman Sepehrvand, Wendimagegn Alemayehu, Padma Kaul, et al.
Canadian Journal of Diabetes|September 12, 2025
Predicting the Risk of COVID-19 Among Adult Patients With Diabetes: A Machine Learning ApproachDean T Eurich, Darren Lau, Weiting Li, et al.
CJC Open|March 15, 2024
Sex Differences in High-Cost Users of Healthcare for Atrial FibrillationRoopinder K Sandhu, Hena Qureshi, Heather Halperin, et al.
Journal of the American Heart Association|July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care SettingsHaran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
Clinical and Experimental Nephrology|August 14, 2023
Kidney function monitoring and trajectories in patients with atrial fibrillationNathaniel M Hawkins, Natasha Wiebe, Jason G Andrade, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|June 28, 2023
Associations between social determinants of health and weight status in preschool children: a population-based studyJessica Wijesundera, Padma Kaul, Anamaria Savu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 22, 2021
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillationRoopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, et al.
Pageof 24